Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Raquel S Laureano, Jenny Sprooten, Isaure Vanmeerbeerk, Daniel M Borras, Jannes Govaerts, Stefan Naulaerts, Zwi N Berneman, Benoit Beuselinck, Kalijn F Bol, Jannie Borst, an Coosemans, Angeliki Datsi, Jitka Fučíková, Lisa Kinget, Bart Neyns, Gerty Schreibelt, Evelien Smits, Rüdiger V Sorg, Radek Spisek, Kris Thielemans, Sandra Tuyaerts, Steven De Vleeschouwer, I Jolanda M de Vries, Yanling Xiao & Abhishek D Garg. (2022) Trial watch: Dendritic cell (DC)-based immunotherapy for cancer. OncoImmunology 11:1.
Read now
Read now
Wei-Ling Li, Ying Zhang, Xiao-Ling Zhang, Yun-Yi Du, Wen-Qing Hu & Jun Zhao. (2022) Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction cancer: A case report. Human Vaccines & Immunotherapeutics 18:6.
Read now
Read now
Duo Yang, Xiaoli Wang, Xinna Zhou, Jing Zhao, Huabing Yang, Shuo Wang, Michael A. Morse, Jiangping Wu, Yanhua Yuan, Sha Li, Amy Hobeika, Herbert Kim Lyerly & Jun Ren. (2021) Blood microbiota diversity determines response of advanced colorectal cancer to chemotherapy combined with adoptive T cell immunotherapy. OncoImmunology 10:1.
Read now
Read now
Articles from other publishers (19)
Celine Man Ying Li, Runhao Li, Paul Drew, Timothy Price, Eric Smith, Guy J. Maddern, Yoko Tomita & Kevin Fenix. (2023) Clinical application of cytokine-induced killer (CIK) cell therapy in colorectal cancer: current strategies and future challenges. Cancer Treatment Reviews, pages 102665.
Crossref
Crossref
Min Dong, Guozhen Zhang, Jie Meng, Biou Liu, Duanfeng Jiang & Feng Liu. (2023) MMP9-Associated Tumor Stem Cells, CCL1-Silenced Dendritic Cells, and Cytokine-Induced Killer Cells Have a Remarkable Therapeutic Efficacy for Acute Myeloid Leukemia by Activating T Cells. Stem Cells International 2023, pages 1-22.
Crossref
Crossref
Wei-Qiang Tan, Li Yuan, Xu Cao, Xiao-Yuan Wu, Yi-Qun Xing & Ming Ye. (2023) Overexpression of lncRNA TUG1 enhances the efficacy of DC-CIK immunotherapy in neuroblastoma in vitro and in vivo. Cancer Biomarkers 36:1, pages 53-61.
Crossref
Crossref
Hanrui Wang, Jianwei Wang, Qiang Wang, Yujuan Yang, Jing Guo, Chao Ren, Yakui Mou, Chuanliang Jia & Xicheng Song. (2022) Laryngeal extra-skeletal Ewing sarcoma treated with DC-CTL immunotherapy: A case report and review of the literature. Frontiers in Oncology 12.
Crossref
Crossref
He Ren, WanJing Li, Xin Liu & Na Zhao. (2022) γδ T cells: The potential role in liver disease and implications for cancer immunotherapy. Journal of Leukocyte Biology 112:6, pages 1663-1668.
Crossref
Crossref
Keywan Mortezaee & Jamal Majidpoor. (2022) NK and cells with NK-like activities in cancer immunotherapy-clinical perspectives. Medical Oncology 39:9.
Crossref
Crossref
Guiyuan Liu, Dehu Chen, Xiaojun Zhao, Xiaolan You, Chuanjiang Huang, Zhiyi Cheng, Xunan Mao & Haihua Zhou. (2022) Efficacy of DC-CIK Immunotherapy Combined with Chemotherapy on Locally Advanced Gastric Cancer. Journal of Oncology 2022, pages 1-6.
Crossref
Crossref
Natalie To, Richard P. T. Evans, Hayden Pearce, Sivesh K. Kamarajah, Paul Moss & Ewen A. Griffiths. (2022) Current and Future Immunotherapy-Based Treatments for Oesophageal Cancers. Cancers 14:13, pages 3104.
Crossref
Crossref
Wuyi Zeng, Jiayi Pan, Zixuan Fang, Jiangtao Jia, Rong Zhang, Menghua He, Hanyu Zhong, Jiashan He, Xinyu Yang, Yi Shi, Bei Zhong, Jun Zeng, Bishi Fu, Maoping Huang & Hui Liu. (2022) A Novel PD-L1-Containing MSLN Targeting Vaccine for Lung Cancer Immunotherapy. Frontiers in Immunology 13.
Crossref
Crossref
Ying-Hua Guan, Na Wang, Zhen-Wei Deng, Xi-Guang Chen & Ya Liu. (2022) Exploiting autophagy-regulative nanomaterials for activation of dendritic cells enables reinforced cancer immunotherapy. Biomaterials 282, pages 121434.
Crossref
Crossref
Yongjian Dong, Shuhui Gao, Xuefang Zhang, Jing Kou, Jing Liu, Ting Ye & Han Shen. (2021) CCL17 and CCL22 induce CCR4 receptor expression and promote cytokine-induced killer cells migration. Anti-Cancer Drugs 33:2, pages 149-157.
Crossref
Crossref
Wen Li, Guanhong Li, Wei Zhou, Hui Wang & Yuqiong Zheng. (2022) Effect of Autoimmune Cell Therapy on Immune Cell Content in Patients with COPD: A Randomized Controlled Trial. Computational and Mathematical Methods in Medicine 2022, pages 1-11.
Crossref
Crossref
Chiara Corti, Pier P.M.B. Giachetti, Alexander M.M. Eggermont, Suzette Delaloge & Giuseppe Curigliano. (2022) Therapeutic vaccines for breast cancer: Has the time finally come?. European Journal of Cancer 160, pages 150-174.
Crossref
Crossref
Paul V. Munson, Lisa H. Butterfield & Juraj Adamik. 2022. Cancer Vaccines as Immunotherapy of Cancer. Cancer Vaccines as Immunotherapy of Cancer
109
135
.
Amit Sharma & Ingo G. H. Schmidt-Wolf. (2021) 30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Crossref
Ying Zhang, Amit Sharma, Hans Weiher, Matthias Schmid, Glen Kristiansen & Ingo G. H. Schmidt-Wolf. (2021) Clinical Studies on Cytokine-Induced Killer Cells: Lessons from Lymphoma Trials. Cancers 13:23, pages 6007.
Crossref
Crossref
Iris A. E. van der Hoorn, Georgina Flórez-Grau, Michel M. van den Heuvel, I. Jolanda M. de Vries & Berber Piet. (2021) Recent Advances and Future Perspective of DC-Based Therapy in NSCLC. Frontiers in Immunology 12.
Crossref
Crossref
Konstantinos Damiris, Hamza Abbad & Nikolaos Pyrsopoulos. (2021) Cellular based treatment modalities for unresectable hepatocellular carcinoma. World Journal of Clinical Oncology 12:5, pages 290-308.
Crossref
Crossref
瑞雪 马. (2021) Research Progress of Adoptive Cellular Immunotherapy in Hematological Malignancies. Advances in Clinical Medicine 11:06, pages 2811-2818.
Crossref
Crossref